The hallmark of systemic lupus erythematosus (SLE) is the loss of immunological tolerance, and B cell hyperactivity. Autoantibodies (autoAbs) against macromolecular complexes, such as chromatin and ...
COM701 with or without nivolumab: Results of an ongoing phase 1 study of safety, tolerability and preliminary antitumor activity in patients with advanced solid malignancies (NCT03667716). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results